In the News
AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 1 & Pt. 2)
A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu explained how growing up near the technology industry...
M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology
Bioinformatics company M2GEN announced a partnership with Microsoft in a move to improve and expand its data-driven solutions for research, discovery, and development of oncology therapies. The collaboration will combine M2GEN’s clinico-genomics database with Microsoft’s healthcare technologies to expand the...
Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies
Be The Match BioTherapies® and Vineti announced a collaboration to create streamlined solutions that alleviate supply chain management difficulties related to cell and gene therapies. The collaboration is non-exclusive and is expected to unite the industry’s top workflow programs: Vineti’s Personalized Therapy...
European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe
Aetion has been selected by the European Medicines Agency to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion is a health care analytics company, working to provide real-world evidence for regulators, manufacturers, and purchasers of medical treatments and technologies. The company was...
Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors
The Saama Board of Directors recently gained some highly respected leaders in Ian Read, former CEO and executive chairman of Pfizer, and Clive Meanwell, former CEO and founder of The Medicines Company. This news was revealed after a $430 million strategic investment in Saama by Carlyle and co-investors including...
THCB Spotlights: Chris Gervais, CTO of Kyruus
Kyruus has grown quite a bit since it first started as a hospital appointment scheduling platform, and the company aims to continue that trend with its recent acquisition of HealthSparq. With this move, the company plans to bridge the gap between providers and payers and expand their presence in both areas. Kyruus...
Survey Says Moms Want In-Person Care With a Side of Digital Health
Digital health company Xealth announced a recent survey examining new mothers and their expectations for digital health in comparison with the healthcare services they received. The survey was conducted among over 1,000 new or expectant mothers, with 57 percent of them showing a more favorable opinion of digital...
AI: Leveraging Wearables and Other Patient-Generated Data in Research
Luca Foschini, PhD, is chief data scientist and co-founder at Evidation Health. In a recent interview he discussed how artificial intelligence interacts with patient-generated data to create advancements in clinical studies for pharmaceutical and biotech companies. Smartphones and smartwatches are used daily around...
Hims & Hers Unveils Mobile Platform For Their Over 500,000 Subscription Members
Hims & Hers announced plans to provide a further encompassing and personalized care experience with the launch of its mobile application. The app is expected to be available for the company’s more than 500,000 subscription members within the coming weeks. Hims & Hers Co-founder and CEO Andrew Dudum detailed...
Clinical Ink Acquires Digital Artefacts
Global clinical trial data and technology company Clinical Ink has announced its acquisition of Digital Artefacts, a digital technology company that specializes in data capture for complex cognitive, behavioral, and physiological research. “Data derived from Digital Artefacts can now increase the richness of our...
Press Releases
OncoHealth Launches New Consumer Platform Bringing Digital Telehealth Services to People with Cancer
OncoHealth, a leading digital health company dedicated to oncology, today unveiled a new digital telehealth service for people with cancer. Iris™ by OncoHealth combines human-centered design, mobile technology, data, empathy, and specially trained oncology experts to...
Augmedix to Report Fourth Quarter and Full Year 2021 Financial Results on March 21, 2022
Medical data service and documentation provider Augmedix recently announced that its fourth quarter and 2021 financial results will be reported on Monday, March 21, 2022, after market close. A conference call discussing these numbers will be held by company management...
CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention
CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, has closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. Other investors participating in the...
IVX Health to Open Three New Infusion Centers in Southwest Florida to Care for Patients Living with Complex Chronic Conditions
IVX Health recently announced the opening of three new centers in Florida’s Southwest in the spring. The centers will be located in the communities of Fort Myers, Naples, and Estero. The company is known as a nationwide provider of injection and infusion therapy...
Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform
Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...